testing. Some authors report that, based on patient history and physical examination, 60-70% of laboratory tests ordered before general surgery are not required. 8 -10 In a recently published study, 11 we could demonstrate that restricting preoperative diagnostics to the recommendations of the current guideline of the Austrian Society of Anaesthesiology (OEGARI) 12 would lead to annual savings of 10 -35 m E in Austria. These findings confirm the results of an earlier published study. 13 Adherence to guidelines on preoperative testing by physicians or even hospitals is often poor. 14 15 The Austrian guideline mentioned above has incorporated international guidelines-like the guideline of the National Institute for Health and Clinical Excellence (NICE) of 2003, 7 the guideline of the American Heart Association (AHA) of 2007, 16 and the Practice Advisory for Preanesthesia Evaluation of the American Society of Anaesthesiologists (ASA) of 2012. 17 These guidelines all agree that the practice of preoperative routine diagnostics is neither justified nor evidence-based. The NICE guideline is based on a HTA report of 1997 6 and a systematic literature update from 1966 to 2002. The HTA report identified 70 studies regarding specified preoperative diagnostics and concludes that very limited data exist on the frequency of perioperative complications and their relation to preoperative tests. The NICE review identified 26 additional relevant studies from 1997 to 2002 that did not change the conclusions of the HTA report. Furthermore, the NICE review identified 21 studies dealing with preoperative pregnancy testing, lung-function tests, and blood gas analysis which had not been included in the HTA report. Here again, the NICE report did not find evidence to justify unselective preoperative screening of healthy individuals if there are no specific reasons for testing derived from patient history or physical examination. Similar conclusions were drawn from the systematic literature review performed by the AHA in 2007 to evaluate cardiac preoperative diagnostics. 16 As the literature search of the NICE guideline included only studies published before March 2002, there is a strong need to update the available evidence regarding non-cardiac preoperative testing to renew and strengthen current recommendations. Neither the recently published Practice advisory for preanaesthesia evaluation of the ASA 17 nor the ESA's guideline for preoperative evaluation of the adult patient undergoing non-cardiac surgery from 2011 18 fulfil this need.
We therefore conducted a systematic review of the literature on preoperative testing in non-cardiac surgery from 2001 to 2011, based on the findings of the NICE review of 2002. 7 Our research questions focus on the effectiveness of noncardiac preoperative testing in elective non-cardiac surgery: † Do preoperative tests of the respiratory system (spirometry and chest X-ray) lead to changes in clinical management, or do they reduce peri-and postoperative complications such as mortality or morbidity (including complications and adverse events) in unselected patients undergoing elective, non-cardiac surgery? † Does preoperative laboratory testing [full blood count, haemostasis, blood gases, renal function, liver function, electrolytes, C-reactive protein (CRP), pregnancy screening, urine analysis, or a set of any of these procedures] lead to changes in clinical management, or does it reduce peri-and postoperative complications such as mortality or morbidity (including complications and adverse events) in unselected patients undergoing elective, non-cardiac surgery?
We used two approaches to search for evidence regarding the effectiveness of preoperative diagnostics. One approach looked at comparisons of a set of preoperative tests (test grid) being routinely performed vs being not performed. The other approach focused on specific preoperative tests analysed separately.
Methods
To provide an update of the NICE review mentioned above, we systematically searched the literature from 2001 to 2011 for studies on the effectiveness of preoperative testing in elective non-cardiac surgery. studies, and used its elements as primary selection criteria. Articles were regarded as potentially eligible if they met all of the criteria depicted in Table 2 .
Exclusion criteria
We excluded the following publication types: case series, pilot studies, studies only reporting data on prevalence or incidence, abstracts, comments, editorials, letters, news, qualitative studies, narrative reviews, and economic studies not based on own original data.
The following procedures were excluded: acute interventions (non-elective surgery), cardiac procedures (e.g. percutaneous coronary interventions, coronary artery bypass grafting, valve surgery, surgery of the ascending thoracic aorta), percutaneous endovascular interventions, angiography, stent placement, and transplant surgery (e.g. liver, lung, kidney, heart). Prognostic or outcome studies for surgery in malignant tumours reporting on, for example, long-term survival after lung resection due to lung carcinoma, were also excluded.
Selection and data extraction
Two reviewers independently screened each title and abstract of a potentially eligible report identified in electronic database and hand searches using Reference Manager & , Version 12.0, with the help of a standardized internal manual. Each article was categorized into one of the three groups: 'yes' (based on title and/or abstract, seems to meet inclusion criteria), 'no' (does not meet the inclusion criteria), and 'background' (useful background material). Six extraction tables and a data extraction form, including a set of parameters for extracting relevant information on preoperative testing, were created. One reviewer extracted the data and a second reviewer independently checked the completeness by reviewing the extraction tables and full-text articles. We required general agreement for inclusion or exclusion of each identified publication. Disagreement between the two researchers was resolved by discussion, and if necessary by arbitration of the senior researcher (A.S.). If available, the patients' physical status according to the classification of the ASA was recorded ( Table 3 ). The severity of surgical procedures was categorized for each study according to the ESC Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery 22 and/or the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery (Table 4) . 23 Detailed information about the data extraction form is provided in Supplementary Appendix SII. The extraction tables with the included studies are available in Supplementary Appendices SIII-SXI. The data extraction of the included studies is provided in the tables as given in these Supplementary appendices.
Assessing study quality and level of evidence
The SIGN handbook 20 was used to grade the level of evidence of each included study (Table 5) .
Results

Included articles
The electronic database searches identified 25 281 articles. After removal of 127 duplicates, we considered 25 154 articles for further analysis. After reviewing titles and abstracts, 24 707 studies were excluded by our exclusion criteria, and 447 articles were ordered for full-text analysis. Of these, we included 97 studies, three randomized controlled trials (RCTs), and 94 observational studies. Four additional observational studies were identified by hand search, making a total of 101 studies. Table 6 shows the results of the literature search. Figure 1 illustrates the PRISMA flowchart of this systematic review.
The three RCTs evaluated the use of test grid vs no testing 24 25 (Supplementary Appendix SX) and one study on pregnancy testing 122 were also included (Supplementary Appendix SXI).
None of the included studies except the three test grid studies mentioned above directly investigated preoperative routine testing vs no testing regarding effects on perioperative mortality or morbidity.
Clinical outcomes of the included studies
Test grid studies Two single-centre RCTs analysed the use of test grids in patients undergoing cataract surgery 24 26 and one 24 when compared with no testing. Postoperative systemic events did not occur in either group. In the second study analysed, the cumulative rate of medical events was 9.6% in the routine testing group compared with 9.7% (P¼0.923) in the selective testing group. 26 Diagnostic testing before ambulatory surgery neither reduced the incidence of intra-and postoperative adverse events (RR 1.0, 95% CI 0.4 -3.0 and RR 0.8, 95% CI 0.4-1.5, respectively) nor the rate of hospital revisits 8-30 days after surgery compared with no testing. Hospital revisits within 7 days were significantly more frequent in the testing group compared with no testing (RR 0.4, 95% CI 0.2-0.9). 25 No study analysed whether the use of routine preoperative test grids reduced the incidence of changes in clinical management compared with no testing or selective testing. No deaths were reported in the studies and therefore no further analysis regarding mortality was done.
Accuracy and predictive value of test grids
None of the included studies provided information on the accuracy and predictive value of the test grid used regarding mortality, complications, or changes in management. However, there was no valid evidence supporting routine (unselective) spirometry in asymptomatic patients. There was no valid evidence supporting routine (unselective) chest X-ray. Neither of the two studies included investigated the association between the test and changes in clinical management or 30 day mortality. 47 53 Postoperative pulmonary complications occurred in 2.7-58.3% of the patients. Neither study showed a significant association between abnormal tests and postoperative pulmonary complications. We included three retrospective 39 60 61 and four prospective cohort studies 35 43 47 52 regarding preoperative blood gas testing. One study involving miscellaneous non-thoracic surgery showed a significant correlation between preoperative blood gas values and postoperative pulmonary complications. 60 However, this result is of only limited validity as it was not confirmed by multivariate analysis. In summary, we did not find evidence to support routine (unselective) preoperative blood gas analysis in patients without history of pulmonary disease. preoperative testing and no testing. Thus, the efficacy of the diagnostic intervention cannot be estimated directly. The studies demonstrated a strong correlation between low haemoglobin levels and the risk for peri-and postoperative blood transfusions, but all studies included healthy subjects and patients with pre-existing anaemia or haematological disease, explaining the correlation.
Accuracy of preoperative pulmonary evaluation
Overall, these results do not permit the conclusion that lower haemoglobin and haematocrit levels are generally correlated to peri-or postoperative complications in healthy subjects without clinical signs or history of anaemia or haematological disease.
In summary, we did not find valid evidence suggesting that routine preoperative haemoglobin or haematocrit testing will lead to a change in clinical management or outcome in patients without pre-existing conditions or signs of anaemia in clinical examination and medical history.
Accuracy of haemoglobin and haematocrit
One study provided data on the accuracy and positive predictive value for 24 h mortality. 76 The accuracy at a lower 
Accuracy of WBC testing
The accuracy and positive predictive value for 24 h mortality were provided in one study. 76 With an upper cut-off of WBC.11 000 mm 3 , the accuracy was 90.2% with a positive predictive value of only 0.15%. 76 No study provided any information on the accuracy of CRP testing.
Haemostasis testing
We included nine very heterogeneous cohort studies analysing the effectiveness of preoperative haemostasis testing (Supplementary Appendix SVIII). 2 71 76 103-108 Six studies used a retrospective study design, and three were prospective trials. No study investigated the association of haemostasis testing and changes in clinical management. Six studies using a multivariate analysis investigated the incidence of adverse events and morbidity, 2 104 106 -108 whereas three studies reported on mortality. 76 106 Two studies found a correlation between an abnormal platelet count and an abnormal international normalized ratio test and the outcomes 'adverse events' or 'morbidity' in patients undergoing elective abdominal surgery. 106 107 One study found a correlation between an abnormal prothrombin time and an abnormal platelet count and mortality in patients undergoing miscellaneous surgeries. 76 In summary, we did not find valid evidence suggesting that routine preoperative haemostasis testing will lead to a change in clinical management or outcome in asymptomatic patients.
Accuracy of platelet count testing
One study reported on the accuracy and positive predictive value for 24 h mortality. 76 The accuracy using an abnormal platelet count definition of platelet count ,150×10 Twenty-three studies evaluated renal testing, five studies electrolyte testing, and one study urine testing. Seven studies were prospective cohort studies; the remaining 18 studies had a retrospective design. Two studies included low-risk procedures 76 97 Five studies reporting about electrolytes were included. 76 The accuracy of urine analysis (positive dip-stick) for surgical site infection was 80.4% with a positive predictive value of 38.5%. 117 The accuracy of other renal function tests, electrolyte tests, and urine analysis evaluated in this systematic review was not provided by the included studies.
Liver function testing
We included seven studies analysing the correlation between liver test results and perioperative mortality and morbidity. None of the studies investigated the association between liver function tests and changes in clinical management (Supplementary Appendix SX). All studies used a cohort study design and were very heterogeneous. Five studies were retrospective 42 69 -71 108 and two study was prospective. 76 121 Three studies 69 71 108 using a multivariate analysis reported on adverse events and morbidity, whereas two studies provided data on mortality. 71 76 Only one study found a correlation between an abnormal total bilirubin, aspartate aminotransferase, or alkaline phosphatase and mortality. 76 However, there was no valid evidence supporting routine (unselective) liver tests in asymptomatic patients.
Accuracy of liver testing
One study provided data on the accuracy and positive predictive value of liver testing for 24 h mortality. 76 with a positive predictive value of 0.23%. The accuracy of other liver tests evaluated in this systematic review was not provided by the included studies.
Pregnancy testing
One study evaluated preoperative pregnancy testing (hCG test in urine) in patients undergoing elective orthopaedic surgery (Supplementary Appendix SXI). Positive pregnancy tests were found in eight (0.31%) of 2588 patients. In seven of these patients, a serum-hCG test was performed to confirm the result. Four tests were positive and three negative. One woman refused the test. The surgery was delayed in the women with a positive serum-hCG test and in the woman refusing the test. 122 
Accuracy of pregnancy testing
The accuracy of preoperative pregnancy testing regarding the detection of pregnancy was calculated to be 99.8%, with a positive predictive value of 50%.
122
Quality of studies and level of evidence
Randomized controlled studies
In all three RCTs analysing the use of test grids, both the intervention group and the control group were well balanced with respect to age, sex, and risk of perioperative complications and also co-morbidities. A systematic randomization method was used in all the studies assessing the study group allocation. The study personnel adequately concealed the allocation in two of the three studies. 24 25 All studies recruited the patients consecutively and used a singleblinded approach. 24 -26 Intraoperative outcomes were assessed from clinical records at the time of discharge. Postoperative complications were assessed by telephone interview 1 month after surgery. Physicians performing the preoperative tests knew for which patients to conduct preoperative testing. 26 Neither of the studies reported losses to follow-up. All included RCTs have a high risk of bias and therefore are categorized as a level of evidence of 1-using the Scottish Intercollegiate Guidelines Network SIGN (www.sign.ac.ak) Levels of Evidence. 20 Observational studies
We did not find controlled intervention studies for single tests, which directly referred to our PICOS framework (does preoperative testing reduce peri-or postoperative mortality
Preoperative tests or morbidity compared with no testing?). The best available evidence is therefore derived from cohort studies and case -control studies with rather small populations. The majority of the studies are retrospective, and in many cases, a clear reporting on a prospective or retrospective design is lacking. This implies considerable risk for selection bias, incomplete documentation of data, and confounding. Retrospective cohort studies should be used in developing or strengthening hypotheses, which requires very large populations. Thus, overall quality of included studies has to be classified as rather low.
Only four studies 31 53 76 82 were graded 2+ according to the level of evidence defined by SIGN; all other studies were graded 22. Studies with a grade of ,22 were not included in our review (see the Inclusion/exclusion criteria sections).
Discussion
Routine preoperative testing in healthy adults undergoing elective non-cardiac surgeries is of questionable benefit, and therefore has already been comprehensively rejected by credible reviews/guidelines and authorities in many countries. In contrast to these recommendations, unselective preoperative testing still is a common standard component preceding elective surgery. The question that still is controversially discussed among some experts is whether we can reduce or eliminate preoperative laboratory testing without any disadvantages for the patient. To explore this question, we cannot use superiority studies, which aim at providing evidence that, for example, a new therapy or diagnostic procedure is more efficient than the state of the art. A more appropriate study design in this case would be equivalence or non-inferiority studies, which aim at the demonstration that the intervention under investigation is not worse than the comparator. First, these study designs require another statistical approach, secondly and most of all these trials have to enrol very large numbers of patients. Such studies have never been performed in the evaluation of preoperative diagnostics, and probably never will be, because they require resources for a large multicentre approach with numerous cases. Thus, Chung and colleagues 25 estimated in their test grid study that a sample size of .20 000 would be necessary to prove non-inferiority of no testing with adequate power. But are we using the correct approach? Routine preoperative testing of healthy subjects has been introduced into daily medical practice without a sound basis of evidence. This approach is very costly to our healthcare systems, and it might even harm surgical patients. So what is the rationale to ask for non-inferiority studies which ought to prove non-inferiority or equivalence to a medical practice that has never been proven to be of any benefit? Should it not be the other way around? We undertook this systematic review to search for evidence supporting the present routine practice of unselective preoperative testing, and we found very little support for this habitual approach to the surgical patient.
The three test grid RCTs included in this systematic review, two involving cataract surgeries and one study covering various types of ambulatory low-risk procedures, do not provide any evidence that preoperative testing might provoke changes in clinical management or reduce morbidity or mortality. It may be considered a limitation that Chung and colleagues 25 only included patients undergoing ambulatory surgery, prohibiting an extrapolation of these results to other settings. On the other hand, the surgical procedures examined included operations performed on patients with significant co-morbidity (.10% classified ASA III), neurosurgery, and spine surgery, 25 which are usually performed in an in-hospital setting throughout Europe. This aspect increases the value of the findings of this study for many institutions. Furthermore, the absence of evidence for the benefit of routine preoperative testing in the ambulatory setting does not imply that this benefit could possibly be shown in the in-hospital setting or in operations with a higher risk of perioperative complications. 2000 which has been included in the NICE review but not in this systematic review due to the time-frame of our search. Besides the three RCTs described above, current evidence on preoperative testing is mainly based on low-quality observational studies, mostly retrospective cohort studies or case series. Overall, the very heterogeneous studies are using different outcome measures and varying abnormal test definitions impeding evaluation. Most of the included studies recruited mainly elderly patients with a variety of comorbidities who were undergoing intermediate-or high-risk surgeries. Thus, the correlations between preoperative test results and outcome rather reflect the correlation between pre-existing co-morbidity and outcome than a consequence of pathological preoperative test results. In addition to this, it needs to be mentioned that data on minor surgical procedures are very scarce. The mere presentation of this correlation does not permit the conclusion that preoperative testing per se predicts perioperative outcome. We undoubtedly have to perform the necessary tests to take care of existing disease before operation, but this does not imply a necessity to perform these tests in otherwise healthy subjects where, based on history, symptoms, and physical findings, we do not suspect the presence of underlying disease. There is no evidence at all to support routine preoperative testing in a younger population undergoing low-risk surgeries-the majority of the patients presenting for noncardiac surgery in clinical practice.
We found a correlation between pathological preoperative tests and outcome in many of the studies in our systematic review. This suggests that preoperative testing in adults undergoing elective, non-cardiac surgery should be performed in selected patients, that is, patients with preexisting diseases or risk factors, or if the patients' history and physical examination reveal indications for such conditions. Thus, the results of our review strongly confirm the NICE guideline which only recommends preoperative testing if the patient's history and physical examination reveal an indication. 7 Spirometry should only be performed in patients with pre-existing pulmonary diseases or risk factors and symptoms such as dyspnoea (on exertion), coughing, or signs of airway obstruction. Haemoglobin and haematocrit need to be examined if there are anamnestic or clinical signs of anaemia or haematological disease. The correlation between haemoglobin, haematocrit, and the need for perioperative transfusions seen in some of the studies is due to the inclusion of patients with these disorders. None of the studies showed that haemoglobin testing of healthy, asymptomatic patients does any good.
Similarly, WBC and CRP should only be performed in selected patients, for example, with risk factors, clinical signs of systemic inflammation, or if the patients' history and physical examination reveal indications for such conditions. Preoperative WBC and CRP testing seems reasonable in orthopaedic (joint replacement) surgeries to exclude a systemic inflammation predisposing for infection of the endoprothesis.
Haemostasis testing and liver testing as well should only be performed in patients with risk factors, history, or physical examination raising suspicion for such conditions.
The strength of our systematic review is its rigorous and extensive search of the literature, and a scrutinous evaluation and selection of relevant studies by at least two independent researchers. It may be considered a limitation that we restricted our search to the years 2001 -2011, and that we did not perform a synopsis of all studies retrieved by the NICE search and our search, thus giving an overview of all relevant studies from 1966 to 2011. The high reputation of the NICE allowed us to rely on the HTA 6 and systematic review performed by NICE 7 up to February 2002, and we provide an overlap of more than 1 yr with the NICE review to assure that no relevant studies are missed. Taken together, the NICE review, its preceding HTA, and our systematic review cover the literature from 1966 to February 2011, and it is unlikely that relevant trials might have been missed by these searches. Also, the findings of our systematic review do not differ relevantly from the NICE results and recommendations requiring a more elaborate synopsis of the studies before and after 2001/2. Extending our search to the years before 2001 would certainly not have altered our results. Owing to the lack of randomized controlled studies, the low number of high-quality trials for each test and outcome parameter, and the heterogeneity of the included studies, neither the NICE reviewers nor we were able to perform a meta-analysis, and thus a combined meta-analysis of the studies retrieved by NICE and by us would also not have been possible.
Conclusion
The most important result of this comprehensive systematic review is that there is no evidence derived from high-quality studies that supports routine preoperative testing in otherwise healthy adult patients undergoing elective non-cardiac surgeries.
The test grid studies included in this systematic review show that there are no significant differences in the incidence of perioperative adverse outcomes between patients with indicated preoperative testing and no testing when cataract surgery or low-risk surgery is performed. Fairly good evidence exists that preoperative routine testing (test grid) in patients undergoing cataract surgery is unnecessary. The observational studies included show that preoperative elective testing in adults undergoing non-cardiac surgery did not induce changes in clinical management, and did not affect mortality, morbidity, or the frequency of adverse events in otherwise healthy subjects. Performing preoperative tests according to a patient's medical history and physical examination seems justified, although high-level evidence from clinical trials does not exist. It seems reasonable to believe that preoperative testing may reduce adverse outcomes in patients undergoing elective non-cardiac surgical procedures only if the test would have been performed anyway in symptomatic subjects. This recommendation is well in accordance with the NICE guideline from 2003.
More research, especially large-scale multicentre RCTs, would be necessary to explore the effectiveness of indicated preoperative testing compared with no testing in elective surgery to support clinicians and policy makers in making informed decisions.
